Clinical Trial Update: Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke [NA]

View source ↗

Summary

This clinical trial update notes that the study evaluating the ReVive SE thrombectomy device for acute treatment of stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ReVive SE Thrombectomy Device

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Stroke | NA | Status: COMPLETED